Skip to main content

Your search for “Therapy Target” returned 457 results

Electric Fields Remove Nanoparticles From Blood With Ease

November 20, 2015

Engineers at the University of California, San Diego developed a new technology that uses an oscillating electric field to easily and quickly isolate drug-delivery nanoparticles from blood. The technology could serve as a general tool to separate and recover nanoparticles from other complex fluids for medical, environmental, and industrial applications.

UC San Diego and Verizon Team to Improve Tuberculosis Care

December 4, 2012

As part of an innovative philanthropic health care program targeting reduction of health care disparities in diverse communities around the United States, the Verizon Foundation has provided the University of California, San Diego School of Medicine with a $300,000 grant, as well as important in-kind health information technology solutions.

Injection of Virus-Delivered Gene Silencer Blocks ALS Degeneration, Saves Motor Function

December 23, 2019

Novel spinal therapy/delivery approach prevented disease onset in neurodegenerative ALS disease model in adult mice and blocked progression in animals already showing disease symptoms.

Acting Student and Bioengineering Alumna Awarded Soros Fellowship for New Americans

April 17, 2024

A University of California San Diego current graduate student in the Department of Theatre and Dance and an undergraduate alumna from the Department of Bioengineering are are among 30 recipients of the 2024 Paul & Daisy Soros Fellowship for New Americans.

Braking Mechanism Identified for Cell Growth Pathway Linked to Several Cancers

June 26, 2015

Researchers at University of California, San Diego School of Medicine have discovered a self-regulating loop in the Hippo pathway, a signaling channel garnering increased attention from cancer researchers due to its role in controlling organ size, cell proliferation and cell death.

Experimental Drug Blocks Toxic Ion Flow Linked to Alzheimer’s Disease

December 5, 2017

A new small-molecule drug can restore brain function and memory in a mouse model of Alzheimer’s disease. The molecule, called anle138b, works by stopping toxic ion flow in the brain that is known to trigger nerve cell death. Scientists envision that this drug could be used to treat Alzheimer’s and…

Engineering Graduate Students Awarded Siebel Scholarship

September 20, 2024

Five UC San Diego graduate students applying engineering principles to solve medical challenges have been selected as 2025 Siebel Scholars. The Siebel Scholars program recognizes the most talented students in the world’s leading graduate schools of business, computer science, bioengineering and energy science.

ARCS Foundation Awards $260,000 to UC San Diego Graduate Students

November 18, 2024

The ARCS Foundation San Diego chapter’s $260,000 gift will support 26 UC San Diego graduate students in the STEM fields for the 2024-25 academic year.

Researchers Produce First Comprehensive Genomic Map of Head and Neck Cancers

January 29, 2015

A team that includes scores of researchers from across the country representing dozens of universities and medical institutions has produced the most comprehensive integrative analysis yet of head and neck squamous cell carcinomas (HNSCCs), a particularly malignant and deadly type of tumor that accounts for roughly 3 percent of all…

Nuclei-free Cells Prove Utility in Delivering Therapeutics to Diseased Tissues

January 14, 2022

UC San Diego researchers report successfully removing the nucleus from a type of ubiquitous cell, then using the genetically engineered cell as a unique cargo-carrier to deliver therapeutics precisely to diseased tissues.Researchers at University of California San Diego School of Medicine and Moores

Category navigation with Social links